TE
Teva Pharmaceutical Industries Limited
TEVJF · OTC
$37.00 +0.00% (+$0.00)
Market Cap $43.1B
P/E Ratio 60.19x
Div. Yield -
ROE 9.19%
Bulios Fair Price
$41.89
13.2% upside
Current Price
$37
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TEVJF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
28 /100
Expensive P/S 2.49x
P/E 60.19x
P/B 5.56x
Growth
68 /100
Growing Book val. growth 0.46%
Rev. growth 7.77%
FCF growth 34.88%
Profitability
58 /100
Moderate Op. margin 15.00%
Gross margin 52.46%
FCF margin 6.09%
Quality
41 /100
Average ROA 1.80%
ROIC 8.98%
Asset turnover 0.43x
Debt
22 /100
High Int. coverage 2.08x
Debt/Equity 2.18x
Net debt/EBITDA 4.03x
Stability
57 /100
Moderate EPS volatility 195.30%
Beta 0.93x
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TEVJF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Richard D. Francis
Employees
33,346
Headquarters
Tel Aviv
Upcoming events
11 NOV
Earnings
Upcoming earnings report